These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30719987)

  • 1. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: Results of a case-control study.
    Singh S; Verma P; Chandra U; Tiwary NK
    Indian J Dermatol Venereol Leprol; 2019; 85(2):197-200. PubMed ID: 30719987
    [No Abstract]   [Full Text] [Related]  

  • 2. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.
    Singh S; Shukla P
    Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinea Faciei: Challenges in the Diagnosis.
    Dev T; Saginatham H; Sethuraman G
    J Pediatr; 2017 Aug; 187():331. PubMed ID: 28433202
    [No Abstract]   [Full Text] [Related]  

  • 4. Tinea faciei in a central Portuguese hospital: A 9-year survey.
    Borges A; Brasileiro A; Galhardas C; Apetato M
    Mycoses; 2018 Apr; 61(4):283-285. PubMed ID: 29285801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology.
    Drake LA; Dinehart SM; Farmer ER; Goltz RW; Graham GF; Hardinsky MK; Lewis CW; Pariser DM; Skouge JW; Webster SB; Whitaker DC; Butler B; Lowery BJ; Elewski BE; Elgart ML; Jacobs PH; Lesher JL; Scher RK
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):282-6. PubMed ID: 8642094
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual clinical presentation of tinea faciei caused by Trichophyton mentagrophytes var. erinacei.
    Lee DW; Yang JH; Choi SJ; Won CH; Chang SE; Lee MW; Choi JH; Moon KC; Kim MN
    Pediatr Dermatol; 2011; 28(2):210-2. PubMed ID: 21504458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Trends of Using Systemic Antifungal Drugs and their Comparative Efficacy in Tinea Corporis and Tinea Cruris in Outpatient Department of Dermatology in a Tertiary Level Hospital.
    Sultana T; Saha SK; Hossain M; Ajmeri S; Sarker M; Sultana M; Nandi AK; Das PK
    Mymensingh Med J; 2018 Jan; 27(1):52-56. PubMed ID: 29459592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczema herpeticum localized to area of tinea cruris.
    Kang SH; Yi JH; Choi HS; Yun SK
    J Dermatol; 2004 Jan; 31(1):60-2. PubMed ID: 14739507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole in the treatment of tinea corporis and tinea cruris.
    Stary A; Sarnow E
    Dermatology; 1998; 196(2):237-41. PubMed ID: 9568414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinea corporis/cruris: new treatment options.
    van Heerden JS; Vismer HF
    Dermatology; 1997; 194 Suppl 1():14-8. PubMed ID: 9154395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative treatment for pityriasis versicolor, tinea cruris, tinea corporis and tinea faciei with topical application of honey, olive oil and beeswax mixture: an open pilot study.
    Al-Waili NS
    Complement Ther Med; 2004 Mar; 12(1):45-7. PubMed ID: 15130571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tinea pseudoimbricata: observations from a clinicoepidemiological and mycological study from eastern India.
    Das A; Sil A; Verma SB; Kumar S
    Clin Exp Dermatol; 2022 Jan; 47(1):147-149. PubMed ID: 34260103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.